DGX vs DNTH · P/E 22, rev $5.94B vs rev $17.8M
Quest Diagnostics Incorporated (DGX) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported DNTH revenue for 2026-06-30 was $17.8M. Net income was -$91.0M. DNTH currently screens at market cap $4.40B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the DGX and DNTH stock pages for the full models.
Not investment advice.